Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
78.4M
-
Number of holders
-
74
-
Total 13F shares, excl. options
-
25.4M
-
Shares change
-
+3.24M
-
Total reported value, excl. options
-
$631M
-
Value change
-
+$87.5M
-
Number of buys
-
59
-
Number of sells
-
-16
-
Price
-
$24.85
Significant Holders of Replimune Group, Inc. - COMMON STOCK (REPL) as of Q2 2020
78 filings reported holding REPL - Replimune Group, Inc. - COMMON STOCK as of Q2 2020.
Replimune Group, Inc. - COMMON STOCK (REPL) has 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.4M shares
of 78.4M outstanding shares and own 32.42% of the company stock.
Largest 10 shareholders include Omega Fund Management, LLC (5.34M shares), Redmile Group, LLC (3.1M shares), BVF INC/IL (2.32M shares), Bain Capital Life Sciences Investors, LLC (2.16M shares), BlackRock Inc. (1.21M shares), FMR LLC (1.13M shares), VICTORY CAPITAL MANAGEMENT INC (1.12M shares), NORGES BANK (905K shares), VANGUARD GROUP INC (886K shares), and EMERALD ADVISERS, LLC (853K shares).
This table shows the top 74 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.